But the scale does not tell you what kind of weight you are losing
When Madeson shared his data with Knudsen in 1995, she realised that it rang a bell because she had noticed that both normal and obese rates experienced a lasting and reversible weight loss when given one of her early GLP-1 analogues
major retailers offer standardized pricing around $349-$499 monthly Explore alternative access paths - Appeal insurance denials with doctor support, check employer benefits, join clinical trials, or consider FDA-approved alternatives Prioritize safety over savings - Only use state-licensed pharmacies and avoid counterfeit products, which are found in nearly half of online sellers Plan for long-term costs - Since GLP-1s require continuous use to maintain results, establish sustainable financial strategies rather than temporary solutions The Inside Rx Blog Get the Inside Scoop on tips & tricks that may help your family save on prescriptions
So, lets sit down and have an honest conversation about your real options, what the science actually says, and what might work best for you
[DOI] [PMC free article] [PubMed] [Google Scholar] 295.Mendoza K., Smith-Warner S.A., Rossato S.L., Khandpur N., Manson J.E., Qi L., Rimm E.B., Mukamal K.J., Willett W.C., Wang M., et al
doi: 10.1161/CIRCULATIONAHA.125.074545 Summary Keywords cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes Citation Aristizbal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, Lpez-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gmez-Mesa J-E, Abreu-Lomba A and Rivera-Martnez W-A (2025) A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists a comprehensive review
